Global Markets Direct's, 'Dengue - Pipeline Review, H2 2012', provides
an overview of the indication's therapeutic pipeline. This report
provides information on the therapeutic development for Dengue, complete
with latest updates, and special features on late-stage and discontinued
projects. It also reviews key players involved in the therapeutic
development for Dengue.

Scope

- A snapshot of the global therapeutic scenario for Dengue.

- A review of the Dengue products under development by companies and
universities/research institutes based on information derived from
company and industry-specific sources.

- Coverage of products based on various stages of development ranging
from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and
combined therapeutics.

- Coverage of the Dengue pipeline on the basis of route of
administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics
under development for Dengue.